The complexity of epilepsy - an overview
My name is Charles, and I'm both a Genome Scientist and the Patient Advocacy & Engagement Lead at Congenica, Cambridge, UK
Congenica Appoints Dr. Muthu Meyyappan as Chief Commercial Officer
Dr. Muthu Meyyappan appointed Chief Commercial Officer (CCO), of Congenica. Based in Boston, MA, Muthu will lead Congenica’s global market expansion.
Congenica Appoints Dr. Sam Roberts as Non-Executive Director
Congenica appoints Dr. Sam Roberts as Non-Executive Director to the Board. Sam is the Managing Director of Health & Care at Legal & General.
Inherited Disorders: Bioinformatic Analysis that Surpasses All Others
A recent study has shown that the Congenica platform demonstrated a superior role identifying the genetic causes of platelet-related bleeding disorders
Congenica Completes $50m Series C Funding Round to Advance Clinical Genomic Analysis Software and Data Platform
New Funds to Drive Further Commercialisation of Rare and Inherited Cancer Applications and Expansion into Oncology, Wellness and Pharma Collaborations
Our plans for the future: a video message from our CEO and Chairman
Congenica CEO David Atkins PhD is joined by Chairman Andy Richards OBE in announcing the company's Series C fundraise.
The culture changes needed to mainstream genomics
We spoke to a number of industry leaders to discuss their thoughts on the culture changes needed to mainstream genomics.
The importance of improving the efficiency of genetic analysis
We spoke to a number of industry leaders to find out their thoughts on the importance of improving the efficiency of genetic analysis.
The benefits and challenges of mainstreaming genomics and precision medicine
We spoke to a number of industry leaders to discuss their thoughts on the benefits and challenges of mainstreaming genomics and precision medicine
Genome UK: the future of healthcare
Congenica's response to the UK Government's national genomic healthcare strategy, setting out its vision to extend the UK’s leadership in genomics
The future of genotype-phenotype data standards to improve outcomes
Supporting Rare Disease Clinical Genomics: The future of genotype phenotype data standards & sharing for analysis to improve medical outcomes
Impact of the Deciphering Developmental Disorders Study
Poster at Rady's Children's Institute Frontiers in Paediatric Medicine Conference discusses the impact of the Deciphering Developmental Disorders study.